Tania Balboni

University of Bologna — Italy

Medicine · Health Sciences

4h-index161citations12works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(5), Monoclonal and Polyclonal Antibodies Research(5), Cancer Cells and Metastasis(2), Neonatal Respiratory Health Research(2), RNA Research and Splicing(2)

Publications12 total

Aerocyte specification and lung adaptation to breathing is dependent on alternative splicing changes
Life Science Alliance·2022· 7 citedOpen Access
Alternative splicing changes are associated with pre-birth adaptation during lung development
2022Open Access
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
Scientific Reports·2021· 10 citedOpen Access
Abstract 716: A novel virus-like particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma
Cancer Research·2018
Abstract 216: Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts
Cancer Research·2018· 1 cited
Mammary carcinoma and angiogenesis: study of the role of HER2 in relation to tumor angiogenesis process and to the sensitivity to anti-tumoral drugs
AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)·2018Open Access
HER2 cancer vaccine optimization by combining Drosophila S2 insect cell manufacturing with a novel VLP-display technology
2018
Virus-like particle display of HER2 induces potent anti-cancer responses
OncoImmunology·2017· 120 citedOpen Access
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
Oncotarget·2017· 23 citedOpen Access
Abstract 1200: HER-2 isoform interaction in mammary carcinoma onset and progression
Cancer Research·2016
Abstract 2774: Coexpression of Delta16 isoform and full-length HER-2 in F1 hybrid transgenic mice: effects on tumor growth and malignancy
Cancer Research·2014
662: HER2 isoforms in mammary carcinogenesis and targeted therapy susceptibility
European Journal of Cancer·2014

Frequent Co-authors

Arianna Palladini(9), Marianna L. Ianzano(9), Pier‐Luigi Lollini(9), Patrizia Nanni(9), Giordano Nicoletti(8), Lorena Landuzzi(8), Veronica Giusti(7), Massimiliano Dall’Ora(6), Carla De Giovanni(6), Roberta Laranga(5), Manuela Iezzi(4), Christoph M. Janitzek(3), Jessica Pihl(3), Adam F. Sander(3), Claudio Ceccarelli(3), Donatella Santini(3), Mario Taffurelli(3), Enrico Di Oto(3), Sofia Asioli(3), Augusto Amici(3)